Impulse (Qingdao) Health Tech Co.,Ltd. (SZSE:002899) announced a private placement of not more than 36,000,000 A shares for gross proceeds of up to CNY 490 million on May 20, 2020. The transaction will include participation from not more than 35 special investors whose shares will be subject to restrictions for six months. The issue price will not be less than 80% of the average price in the 20 trading days before the pricing reference date. The transaction has been approved by at the second meeting of the second directorate in 2020 of the company, and are subject to the approval of the company's shareholders meeting and the China Securities Regulatory Commission.